Thalidomide

貨號 Cat. No.
S1193
規格 Size
5~200mg
品牌 Brand
Selleckchem

Description

 



Thalidomide
Catalog No.S1193

Thalidomide was introduced as a sedative drug, immunomodulatory agent and also is investigated for treating symptoms of many cancers. Thalidomide inhibits an E3 ubiquitin ligase, which is a CRBN-DDB1-Cul4A complex.Phase 3.


















Size Price Stock Quantity  
















10mM/1mLIn DMSO USD 239 In stock  
0
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
200mg USD 185 In stock  
0
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 




Distributor Tel: +886-2-2827-1197jimmy@new.abscience.com.tw


Biological Activity


 


Thalidomide was introduced as a sedative drug in the late 1950s. However, it was withdrawn due to a teratogenic effect on fetal development. Thalidomide binds to inactivate the protein cereblon, which is important to limb formation. [1]

There is now a growing clinical interest in thalidomide since it is introduced as an immunomodulatory agent used primarily, combined with dexamethasone, to treat multiple myeloma. The combination of thalidomide and dexamethasone, often in combination with melphalan, is now one of the most common regimens for patients with newly diagnosed multiple myeloma, with an improved response rate of up to 60-70%. [1]


 


Clinical Trial Information( data from http://clinicaltrials.gov)





















































NCT Number Recruitment Conditions Sponsor

/Collaborators
Start Date Phases
NCT01927718 Not yet recruiting Myeloma M.D. Anderson Cancer Center|Celgene Corporation 2014-02  
NCT01889420 Not yet recruiting Multiple Myeloma in Relapse New Mexico Cancer Care Alliance|Novartis Corporation 2014-02 Phase 1
NCT02018523 Not yet recruiting Carcinoma, Non-Small-Cell Lung Baylor College of Medicine|Jun Zhang|Celgene Corporation 2014-02 Phase 1
NCT01946152 Not yet recruiting Myeloma M.D. Anderson Cancer Center|Celgene Corporation 2014-02 Phase 1|Phase 2
NCT01996865 Not yet recruiting Lymphoma, Non-Hodgkin Celgene Corporation 2014-02 Phase 3

Chemical Information


Download Thalidomide SDF


 

















Molecular Weight (MW) 258.23
Formula

C13H10N2O4


CAS No. 50-35-1















Storage 3 years -20℃Powder
6 months-80℃in DMSO
Syonnyms Thalomid

 


























Solubility (25°C) * In vitro DMSO 52 mg/mL (201 mM)
Water <1 mg/mL (<1 mM)
Ethanol 2 mg/mL (7 mM)
In vivo 30% PEG400/0.5% Tween80/5% propylene glycol, 5 mg/mL
* <1 mg/ml means slightly soluble or insoluble.

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.


 








Chemical Name  

 

Preparing Stock Solutions



















Stock Solution (1ml DMSO) 1mM 10mM 20mM 30mM
Mass(mg) 0.25823 2.5823 5.1646 7.7469


 


 


 

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢